scPharmaceuticals Solutions

Delivering a New Approach to Patient Care

scPharmaceuticals is changing treatment paradigms and reducing the burden of disease by delivering proven drugs through a new route of administration. scPharmaceuticals takes proven drugs that were once only available intravenously (IV), and makes them available subcutaneously.

Drug_Device_Intersection

Solving Problems

Subcutaneous delivery solves many problems for patients who depend on IV drugs:

  • Less discomfort
  • No need to travel to a clinical setting
  • No need for PIC (peripherally inserted central catheter) line placement
  • Lower cost

Deploying Innovative Technology

The medical device that makes subcutaneous delivery possible is the sc2Wear™ Infusor*, a small pump that attaches to the body using a standard medical adhesive. The sc2Wear™ Infusor introduces the drug into the body slowly, similar to an IV drip. It avoids the skin effects and pain that could result from a faster, subcutaneous injection of a high-volume medication.

Subcutaneous delivery with the sc2Wear™ Infusor is generally just as effective as IV delivery.

Working with Proven Drugs

The sc2Wear™ Infusor is tested with specific medications to ensure that the medication can be successfully delivered. The medication is then packaged with the sc2Wear™ Infusor. The drug-device combination is distributed, dispensed and reimbursed as a pharmaceutical.

Two of the first medications being tested with the sc2Wear™ Infusor are furosemide for congestive heart failure and edema, and ceftriaxone for certain bacterial infections.

With the combination of proven drugs and the sc2Wear™ Infusor, scPharmaceuticals is delivering a better treatment experience for patients.

View scPharmaceuticals Pipeline

UPDATE: scPharmaceuticals announced positive pivotal trial results for its proprietary furosemide for subcutaneous delivery and the start of its pivotal trial for the subcutaneous delivery of ceftriaxone.

Reference:

*CAUTION: Investigational Product – Limited by Federal Law to Investigational Use.